0001213900-15-003852.txt : 20150515
0001213900-15-003852.hdr.sgml : 20150515
20150515160117
ACCESSION NUMBER: 0001213900-15-003852
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150515
DATE AS OF CHANGE: 20150515
EFFECTIVENESS DATE: 20150515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Redwood Scientific Technologies, Inc.
CENTRAL INDEX KEY: 0001634394
IRS NUMBER: 473165559
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-240036
FILM NUMBER: 15868846
BUSINESS ADDRESS:
STREET 1: 250 W 1ST STREET
STREET 2: SUITE 310
CITY: CLAREMONT
STATE: CA
ZIP: 91711
BUSINESS PHONE: 310-693-5401
MAIL ADDRESS:
STREET 1: 250 W 1ST STREET
STREET 2: SUITE 310
CITY: CLAREMONT
STATE: CA
ZIP: 91711
D
1
primary_doc.xml
X0707
D
LIVE
0001634394
Redwood Scientific Technologies, Inc.
250 WEST. FIRST STREET
SUITE 310
CLAREMONT
CA
CALIFORNIA
91711
570-470-6155
NEVADA
None
None
Corporation
true
2014
Cardiff
Jason
250 West First Street
Suite 310
Claremont
CA
CALIFORNIA
91711
Executive Officer
Director
Jacques
Poujade
250 West First Street
Suite 310
Claremont
CA
CALIFORNIA
91711
Executive Officer
Eunjung
Cardiff
250 West First Street
Suite 310
Claremont
CA
CALIFORNIA
91711
Director
Jaci
Warren
250 West First Street
Suite 310
Claremont
CA
CALIFORNIA
91711
Director
Christine
Hayes
250 West First Street
Suite 310
Claremont
CA
CALIFORNIA
91711
Director
Other Health Care
Decline to Disclose
- 06b
false
2015-04-30
false
true
true
false
22500
Halen Capital Management
135966
None
None
301 SOUTH MISSOURI AVENUE, 2ND FLOOR
CLEARWATER
FL
FLORIDA
33756
AL
ALABAMA
AR
ARKANSAS
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
FL
FLORIDA
GA
GEORGIA
ID
IDAHO
IL
ILLINOIS
IN
INDIANA
KY
KENTUCKY
LA
LOUISIANA
MD
MARYLAND
MA
MASSACHUSETTS
MI
MICHIGAN
MN
MINNESOTA
MT
MONTANA
NV
NEVADA
NJ
NEW JERSEY
NY
NEW YORK
NC
NORTH CAROLINA
OH
OHIO
OK
OKLAHOMA
OR
OREGON
PA
PENNSYLVANIA
TN
TENNESSEE
TX
TEXAS
WY
WYOMING
PR
PUERTO RICO
false
Newport Coast Securities, Inc.
16944
None
None
180 MAIDEN LANE
17 FLOOR
NY
NY
NEW YORK
10038
All States
false
5000000
500000
4500000
The Offering has an over-allotment option of $500,000 additional Units.
false
3
300000
true
0
Commission is based on total amount sold: 6% cash fee; warrants to purchase 8% of securities sold. 2% non-accountable expense fee based on the total amount sold also payable.
0
false
Redwood Scientific Technologies, Inc.
/s/ Jason Cardiff
Jason Cardiff
CEO
2015-05-15